127 related articles for article (PubMed ID: 9375877)
1. Low dose amitriptyline in ankylosing spondylitis: a short term, double blind, placebo controlled study.
Koh WH; Pande I; Samuels A; Jones SD; Calin A
J Rheumatol; 1997 Nov; 24(11):2158-61. PubMed ID: 9375877
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of methotrexate in ankylosing spondylitis: a randomized, double blind, placebo controlled trial.
Gonzalez-Lopez L; Garcia-Gonzalez A; Vazquez-Del-Mercado M; Muñoz-Valle JF; Gamez-Nava JI
J Rheumatol; 2004 Aug; 31(8):1568-74. PubMed ID: 15290737
[TBL] [Abstract][Full Text] [Related]
3. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.
Brandt J; Khariouzov A; Listing J; Haibel H; Sörensen H; Grassnickel L; Rudwaleit M; Sieper J; Braun J
Arthritis Rheum; 2003 Jun; 48(6):1667-75. PubMed ID: 12794835
[TBL] [Abstract][Full Text] [Related]
4. Clinimetric evaluation of the bath ankylosing spondylitis metrology index in a controlled trial of pamidronate therapy.
Jauregui E; Conner-Spady B; Russell AS; Maksymowych WP
J Rheumatol; 2004 Dec; 31(12):2422-8. PubMed ID: 15570645
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).
van der Heijde D; Dijkmans B; Geusens P; Sieper J; DeWoody K; Williamson P; Braun J;
Arthritis Rheum; 2005 Feb; 52(2):582-91. PubMed ID: 15692973
[TBL] [Abstract][Full Text] [Related]
6. A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.
Maksymowych WP; Jhangri GS; Fitzgerald AA; LeClercq S; Chiu P; Yan A; Skeith KJ; Aaron SL; Homik J; Davis P; Sholter D; Russell AS
Arthritis Rheum; 2002 Mar; 46(3):766-73. PubMed ID: 11920413
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug.
Dougados M; Béhier JM; Jolchine I; Calin A; van der Heijde D; Olivieri I; Zeidler H; Herman H
Arthritis Rheum; 2001 Jan; 44(1):180-5. PubMed ID: 11212158
[TBL] [Abstract][Full Text] [Related]
8. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis.
van Ophoven A; Pokupic S; Heinecke A; Hertle L
J Urol; 2004 Aug; 172(2):533-6. PubMed ID: 15247722
[TBL] [Abstract][Full Text] [Related]
9. Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis.
van Denderen JC; van der Paardt M; Nurmohamed MT; de Ryck YM; Dijkmans BA; van der Horst-Bruinsma IE
Ann Rheum Dis; 2005 Dec; 64(12):1761-4. PubMed ID: 15901634
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial.
Braun J; Brandt J; Listing J; Zink A; Alten R; Burmester G; Golder W; Gromnica-Ihle E; Kellner H; Schneider M; Sörensen H; Zeidler H; Reddig J; Sieper J
Arthritis Rheum; 2003 Aug; 48(8):2224-33. PubMed ID: 12905476
[TBL] [Abstract][Full Text] [Related]
11. Celecoxib is efficacious and well tolerated in treating signs and symptoms of ankylosing spondylitis.
Barkhuizen A; Steinfeld S; Robbins J; West C; Coombs J; Zwillich S
J Rheumatol; 2006 Sep; 33(9):1805-12. PubMed ID: 16960941
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
13. Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS).
Revicki DA; Luo MP; Wordsworth P; Wong RL; Chen N; Davis JC;
J Rheumatol; 2008 Jul; 35(7):1346-53. PubMed ID: 18484692
[TBL] [Abstract][Full Text] [Related]
14. Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly.
Braun J; McHugh N; Singh A; Wajdula JS; Sato R
Rheumatology (Oxford); 2007 Jun; 46(6):999-1004. PubMed ID: 17389658
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis.
Calin A; Dijkmans BA; Emery P; Hakala M; Kalden J; Leirisalo-Repo M; Mola EM; Salvarani C; Sanmartí R; Sany J; Sibilia J; Sieper J; van der Linden S; Veys E; Appel AM; Fatenejad S
Ann Rheum Dis; 2004 Dec; 63(12):1594-600. PubMed ID: 15345498
[TBL] [Abstract][Full Text] [Related]
16. Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept.
Davis JC; Van der Heijde DM; Dougados M; Braun J; Cush JJ; Clegg DO; Inman RD; de Vries T; Tsuji WH
J Rheumatol; 2005 Sep; 32(9):1751-4. PubMed ID: 16142873
[TBL] [Abstract][Full Text] [Related]
17. Improvement in hemoglobin levels in patients with ankylosing spondylitis treated with infliximab.
Braun J; van der Heijde D; Doyle MK; Han C; Deodhar A; Inman R; de Vlam K; Burmester GR; Van den Bosch F; Xu S; Visvanathan S; Rahman MU
Arthritis Rheum; 2009 Aug; 61(8):1032-6. PubMed ID: 19644896
[TBL] [Abstract][Full Text] [Related]
18. Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms.
Kautio AL; Haanpää M; Saarto T; Kalso E
J Pain Symptom Manage; 2008 Jan; 35(1):31-9. PubMed ID: 17980550
[TBL] [Abstract][Full Text] [Related]
19. Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial.
Gür A; Karakoc M; Nas K; Cevik R; Sarac J; Ataoglu S
Rheumatol Int; 2002 Sep; 22(5):188-93. PubMed ID: 12215864
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of mesalazine (Salofalk) in an open study of 20 patients with ankylosing spondylitis.
van Denderen JC; van der Horst-Bruinsma I; Bezemer PD; Dijkmans BA
J Rheumatol; 2003 Jul; 30(7):1558-60. PubMed ID: 12858458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
